First round of Abstract Submissions is open now..!
Don't miss the opportunity! Submit your abstract for the first round by November 28, 2025.
First round of Abstract Submissions is open now..!
Don't miss the opportunity! Submit your abstract for the first round by November 28, 2025.
This session investigates the critical role of post-marketing monitoring (PMS) in guaranteeing the long-term safety and efficacy of licensed medications. Participants will learn about best practices, regulatory requirements, and innovative methods for monitoring adverse events, assessing real-world outcomes, and preserving public faith in pharmacotherapy.